Eamonn Connolly

Eamonn Connolly appears in our data through filings on Infant Bacterial Therapeutics AB shares, published by Finansinspektionen. Over a trading history stretching from 28 June 2017 to 3 December 2020, the count stands at 10 filings.

In open-market terms, that means 3 purchases worth €56k on one side and 7 sales worth €51k on the other. The net balance comes to €5,460 on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2020: 2 purchases and no sales on the market.

In size, the median ticket on the buying side is €22k. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The latest filing, published on 7 December 2020, reports an open-market purchase of €11k in Infant Bacterial Therapeutics AB. Filings reach the Finansinspektionen feed a median of 1 day after the trade. The regulation allows three business days to notify a trade (MAR article 19). Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.